212 related articles for article (PubMed ID: 36653361)
1. Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma.
Ferguson LP; Gatchalian J; McDermott ML; Nakamura M; Chambers K; Rajbhandari N; Lytle NK; Rosenthal SB; Hamilton M; Albini S; Wartenberg M; Zlobec I; Galván JA; Karamitopoulou E; Vavinskaya V; Wascher A; Lowy AM; Schürch CM; Puri PL; Bruneau BG; Hargreaves DC; Reya T
Nat Commun; 2023 Jan; 14(1):292. PubMed ID: 36653361
[TBL] [Abstract][Full Text] [Related]
2. The role of the SWI/SNF chromatin remodeling complex in pancreatic ductal adenocarcinoma.
Tsuda M; Fukuda A; Kawai M; Araki O; Seno H
Cancer Sci; 2021 Feb; 112(2):490-497. PubMed ID: 33301642
[TBL] [Abstract][Full Text] [Related]
3. TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes.
Eyres M; Lanfredini S; Xu H; Burns A; Blake A; Willenbrock F; Goldin R; Hughes D; Hughes S; Thapa A; Vavoulis D; Hubert A; D'Costa Z; Sabbagh A; Abraham AG; Blancher C; Jones S; Verrill C; Silva M; Soonawalla Z; Maughan T; Schuh A; Mukherjee S; O'Neill E
Gastroenterology; 2021 Aug; 161(2):653-668.e16. PubMed ID: 33915173
[TBL] [Abstract][Full Text] [Related]
4. Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma.
Fox RG; Lytle NK; Jaquish DV; Park FD; Ito T; Bajaj J; Koechlein CS; Zimdahl B; Yano M; Kopp J; Kritzik M; Sicklick J; Sander M; Grandgenett PM; Hollingsworth MA; Shibata S; Pizzo D; Valasek M; Sasik R; Scadeng M; Okano H; Kim Y; MacLeod AR; Lowy AM; Reya T
Nature; 2016 Jun; 534(7607):407-411. PubMed ID: 27281208
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic Landscape in Pancreatic Ductal Adenocarcinoma: On the Way to Overcoming Drug Resistance?
Ciernikova S; Earl J; García Bermejo ML; Stevurkova V; Carrato A; Smolkova B
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32521716
[TBL] [Abstract][Full Text] [Related]
6. Role of epigenetics in pancreatic ductal adenocarcinoma.
Pandey S; Gupta VK; Lavania SP
Epigenomics; 2023 Jan; 15(2):89-110. PubMed ID: 36647796
[TBL] [Abstract][Full Text] [Related]
7. LncRNA PWAR6 regulates proliferation and migration by epigenetically silencing YAP1 in tumorigenesis of pancreatic ductal adenocarcinoma.
Huang S; Li Y; Hu J; Li L; Liu Z; Guo H; Jiang B; Chen J; Li J; Xiang X; Deng J; Xiong J
J Cell Mol Med; 2021 May; 25(9):4275-4286. PubMed ID: 33834618
[TBL] [Abstract][Full Text] [Related]
8. BRD9-SMAD2/3 Orchestrates Stemness and Tumorigenesis in Pancreatic Ductal Adenocarcinoma.
Feng Y; Cai L; Pook M; Liu F; Chang CH; Mouti MA; Nibhani R; Militi S; Dunford J; Philpott M; Fan Y; Fan GC; Liu Q; Qi J; Wang C; Hong W; Morgan H; Wang M; Sadayappan S; Jegga AG; Oppermann U; Wang Y; Huang W; Jiang L; Pauklin S
Gastroenterology; 2024 Jan; 166(1):139-154. PubMed ID: 37739089
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic resistance of pancreatic cancer: Roadmap to its reversal.
Yu S; Zhang C; Xie KP
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188461. PubMed ID: 33157162
[TBL] [Abstract][Full Text] [Related]
10. Loss of ARID1A Promotes Epithelial-Mesenchymal Transition and Sensitizes Pancreatic Tumors to Proteotoxic Stress.
Tomihara H; Carbone F; Perelli L; Huang JK; Soeung M; Rose JL; Robinson FS; Lissanu Deribe Y; Feng N; Takeda M; Inoue A; Poggetto ED; Deem AK; Maitra A; Msaouel P; Tannir NM; Draetta GF; Viale A; Heffernan TP; Bristow CA; Carugo A; Genovese G
Cancer Res; 2021 Jan; 81(2):332-343. PubMed ID: 33158812
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic Alterations in Pancreatic Cancer Metastasis.
Wang SS; Xu J; Ji KY; Hwang CI
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439749
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?
Hessmann E; Johnsen SA; Siveke JT; Ellenrieder V
Gut; 2017 Jan; 66(1):168-179. PubMed ID: 27811314
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic therapeutic strategies in pancreatic cancer.
Orlacchio A; Muzyka S; Gonda TA
Int Rev Cell Mol Biol; 2024; 383():1-40. PubMed ID: 38359967
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Rewiring and Stemness: A Critical Attribute of Pancreatic Cancer Progression.
Ogunleye AO; Nimmakayala RK; Batra SK; Ponnusamy MP
Stem Cells; 2023 May; 41(5):417-430. PubMed ID: 36869789
[TBL] [Abstract][Full Text] [Related]
15. The SWI/SNF subunit SMARCD3 regulates cell cycle progression and predicts survival outcome in ER+ breast cancer.
Tropée R; de la Peña Avalos B; Gough M; Snell C; Duijf PHG; Dray E
Breast Cancer Res Treat; 2021 Feb; 185(3):601-614. PubMed ID: 33180234
[TBL] [Abstract][Full Text] [Related]
16. PHLPP2 is a novel biomarker and epigenetic target for the treatment of vitamin C in pancreatic cancer.
Chen L; Song H; Luo Z; Cui H; Zheng W; Liu Y; Li W; Luo F; Liu J
Int J Oncol; 2020 May; 56(5):1294-1303. PubMed ID: 32319585
[TBL] [Abstract][Full Text] [Related]
17. SWI/SNF chromatin-remodeling factor Smarcd3/Baf60c controls epithelial-mesenchymal transition by inducing Wnt5a signaling.
Jordan NV; Prat A; Abell AN; Zawistowski JS; Sciaky N; Karginova OA; Zhou B; Golitz BT; Perou CM; Johnson GL
Mol Cell Biol; 2013 Aug; 33(15):3011-25. PubMed ID: 23716599
[TBL] [Abstract][Full Text] [Related]
18. ARID1B, a member of the human SWI/SNF chromatin remodeling complex, exhibits tumour-suppressor activities in pancreatic cancer cell lines.
Khursheed M; Kolla JN; Kotapalli V; Gupta N; Gowrishankar S; Uppin SG; Sastry RA; Koganti S; Sundaram C; Pollack JR; Bashyam MD
Br J Cancer; 2013 May; 108(10):2056-62. PubMed ID: 23660946
[TBL] [Abstract][Full Text] [Related]
19. Loss of ARID1A Expression Correlates With Tumor Differentiation and Tumor Progression Stage in Pancreatic Ductal Adenocarcinoma.
Zhang L; Wang C; Yu S; Jia C; Yan J; Lu Z; Chen J
Technol Cancer Res Treat; 2018 Jan; 17():1533034618754475. PubMed ID: 29486633
[TBL] [Abstract][Full Text] [Related]
20. Loss of KDM6A characterizes a poor prognostic subtype of human pancreatic cancer and potentiates HDAC inhibitor lethality.
Watanabe S; Shimada S; Akiyama Y; Ishikawa Y; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Kudo A; Yamaoka S; Tanabe M; Tanaka S
Int J Cancer; 2019 Jul; 145(1):192-205. PubMed ID: 30556125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
